» Authors » Yikuan Feng

Yikuan Feng

Explore the profile of Yikuan Feng including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 214
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang Q, Geng P, Zhang Y, Yang M, Zhu J, Zhang M, et al.
Medicine (Baltimore) . 2024 Jun; 103(23):e38244. PMID: 38847676
Background: Numerous studies have investigated the association between CDH1 polymorphisms and gastric cancer (GC) risk. However, the results have been inconsistent and controversial. To further determine whether CDH1 polymorphisms increase...
2.
Yang M, Liu Y, Zheng S, Geng P, He T, Lu L, et al.
Aging (Albany NY) . 2024 Mar; 16(7):6068-6097. PMID: 38546391
Programmed death-1 and its ligand-1 (PD-1/PD-L1), immune checkpoints proteins, play a crucial role in anti-tumor responses. A large number of studies have evaluated the relationships of PD-1/PD-L1 polymorphisms with risk...
3.
Feng J, Wang L, Feng Y, Yu G, Zhou D, Wang J
Exp Ther Med . 2022 May; 23(5):362. PMID: 35493434
It has been reported that angiopoietin 2 (Ang-2) plays an integral role in the pathophysiology of sepsis and many other inflammatory diseases. However, the specific role of Ang-2 in septic...
4.
Bian Y, Le Y, Du H, Chen J, Zhang P, He Z, et al.
Front Med (Lausanne) . 2022 Jan; 8:786414. PMID: 35004751
To explore the efficacy of anticoagulation in improving outcomes and safety of Coronavirus disease 2019 (COVID-19) patients in subgroups identified by clinical-based stratification and unsupervised machine learning. This single-center retrospective...
5.
Zhou S, Feng J, Xie Q, Huang T, Xu X, Zhou D, et al.
Phytomedicine . 2021 Jun; 89:153612. PMID: 34126419
Background: Coronavirus disease 2019 (COVID-19) is still a pandemic, with a high mortality rate in severe/critical cases. Therapies based on the Shenghuang Granule have proved helpful in viral infection and...
6.
Zheng Z, Li J, An J, Feng Y, Wang L
Diagn Pathol . 2021 Jan; 16(1):5. PMID: 33430926
Background: Gastric cancer (GCa) is one of the six major malignancies in the world with low survival rate. Although there are advances in therapeutic approaches, the prognosis of patients with...
7.
Zhang P, He Z, Yu G, Peng D, Feng Y, Ling J, et al.
Clin Nutr . 2020 Jun; 40(2):534-541. PMID: 32527576
Background & Aims: In the newly emerged Coronavirus Disease 2019 (COVID-19) disaster, little is known about the nutritional risks for critically ill patients. It is also unknown whether the modified...
8.
Liu Y, Zhou C, Zhang K, Feng Y, Zhang R
Medicine (Baltimore) . 2018 Nov; 97(47):e13259. PMID: 30461630
Background: Apatinib-targeted therapy is considered a promising treatment option for malignancies. This study systematically evaluated the efficacy and safety of the combination of apatinib and S-1 for the treatment of...
9.
Liu Y, Zheng Z, Zhang Q, Zhou X, Feng Y, Yan A
Onco Targets Ther . 2017 Jun; 10:2621-2633. PMID: 28572734
Purpose: To systematically investigate the efficacy and safety of the combination of FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin) regimen and cocultured dendritic cells and cytokine-induced killer cells (DC-CIK) immunotherapy for the...
10.
Wang M, Gao P, Wu X, Chen Y, Feng Y, Yang Q, et al.
Respir Res . 2016 Nov; 17(1):153. PMID: 27852250
Background: Steroid resistant (SR) asthma is characterized by persistent airway inflammation that fails to resolve despite treatment with high doses of corticosteroids. Furthermore, SR patient airways show increased numbers neutrophils,...